Christopher B Prentiss
CIK 1717583 · Chief Financial Officer · last filed 2026-04-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.24M
Companies
2
Total Filings
24
Lifetime Open-Market Net
-$95.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MNKD | Chief Financial Officer | 338,924 | $3.66 | $1.24M | $0 | 7 | 2026-04-24 |
| Adamas Pharmaceuticals Inc (ADMS) Delisted | Chief Financial Officer | 0 | $8.22 | $0 | -$95.7K | 17 | 2021-11-24 |
Recent Filings · Page 3 of 3
24 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-12-26 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Sell (S) | −228 | -$1.7K | EDGAR |
| 2018-03-22 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Sell (S) | −567 | -$14.7K | EDGAR |
| 2018-03-09 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Grant (A) | +5,000 | $0 | EDGAR |
| 2017-10-10 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Grant (A) | +2,500 | $0 | EDGAR |
Showing 21–24 of 24
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.